Capital Investment Counsel LLC lowered its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 15.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,910 shares of the financial services provider’s stock after selling 741 shares during the quarter. Capital Investment Counsel LLC’s holdings in Aflac were worth $404,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Franklin Resources Inc. grew its stake in Aflac by 75.2% during the third quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock worth $88,533,000 after buying an additional 333,083 shares during the last quarter. Aptus Capital Advisors LLC boosted its stake in Aflac by 79.7% in the third quarter. Aptus Capital Advisors LLC now owns 27,354 shares of the financial services provider’s stock worth $3,058,000 after purchasing an additional 12,131 shares in the last quarter. Transamerica Financial Advisors Inc. bought a new position in shares of Aflac in the third quarter worth about $979,000. FMR LLC raised its stake in shares of Aflac by 4.0% in the third quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after acquiring an additional 45,745 shares during the last quarter. Finally, Fulton Breakefield Broenniman LLC bought a new position in shares of Aflac in the third quarter worth about $250,000. 67.44% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.90% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on AFL
Aflac Trading Down 0.7 %
NYSE:AFL opened at $107.39 on Wednesday. Aflac Incorporated has a fifty-two week low of $75.07 and a fifty-two week high of $115.50. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. The stock has a market capitalization of $59.66 billion, a PE ratio of 16.17, a price-to-earnings-growth ratio of 2.10 and a beta of 1.00. The business’s 50-day simple moving average is $105.81 and its 200-day simple moving average is $106.15.
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The business had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. During the same period last year, the business posted $1.84 earnings per share. The firm’s quarterly revenue was down 40.4% on a year-over-year basis. Sell-side analysts expect that Aflac Incorporated will post 7.26 earnings per share for the current fiscal year.
Aflac Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be issued a dividend of $0.58 per share. The ex-dividend date of this dividend is Wednesday, February 19th. This is an increase from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.16%. Aflac’s dividend payout ratio (DPR) is presently 30.12%.
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Why Invest in 5G? How to Invest in 5G Stocks
- What Does the Future Hold for Eli Lilly?
- P/E Ratio Calculation: How to Assess Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.